HArmonyCa Hong Kong

he preauricular region of 15 women. The primary endpoint were the volumetric changes at Day 180. Secondary endpoints included changes in facial tension vectors, time to filler tissue integration and safety profile.¹†Results from a pre-clinical animal study of HArmonyCa™ with results demonstrated over 8 weeks.²

References: 1. Urdiales-Gálvez F et al., J Cosmet Dermatol. 2023 Aug;22(8):2186-219; 2. REF-84450. HArmonyCa™ Lidocaine INT-HAR-2150040. Collagen stimulation. July 2021; 3. HArmonyCa™ IFU. 20072591. M049 V02/P01. Revision December 2021; 4. Gonzalez N, Goldberg. J. Dermatol Surg. 2019;45:547–551; 5. Bravo B et al. Plast Reconstr Surg Glob Open. 2023;15(11):1–10; 6. HArmonyCa™ Lidocaine INT-HAR-2150036. Lift capacity. July 2021. REF-84448; 7. HArmonyCa™ Lidocaine. Clinical Study Report. July 2022. REF-99624. BOTOX®保妥適®註冊藥物號碼: HK-41906. Juvéderm® 喬雅登® (Hyaluronic Acid Gel with Lidocaine) 產品系列包括 VOLUX™ (HKMD-190341), VOLUMA® (HKMD-100411), VOLIFT® (HKMD-130324), VOLBELLA®(HKMD-210451) 及VOLITE™ (HKMD-180040). HArmonyCaTM (calcium hydroxyapatite, hyaluronic acid gel with lidocaine).

請向醫生或醫學美容中心諮詢。療程效果因人而異。療程後如有任何不良反應，請即向醫生查詢。All adverse events should be reported to [email protected]. 香港北角電氣道 183 號友邦廣場 24 樓 2404-08 室; 電話: (852)26102525 © 2024 Allergan Aesthetics. All rights reserved. HK-HAR-240042 | 02/SEP/24

AbbVie’s HArmonyCa™ Hong Kong Facebook Community Guidelines

Thanks for visiting AbbVie’s HArmonyCa™ Hong Kong pages. Our teams use this page to share information relevant to HArmonyCa™ products and our local business, including news about Allergan Aesthetics, industry news, products news, content education on aesthetics field, and more. Content on this channel is intended for Hong Kong SAR audiences only. If you are viewing this from outside of such region, please visit our global corporate account at https://www.facebook.com/AllerganAesthetics. We welcome the opportunity to hear from you on Facebook. If you comment or ask questions, please follow these Community Guidelines to ensure we provide you the best experience. Please remember that we work in a highly regulated industry with unique legal considerations. We cannot engage in sensitive topics or discussions about our products, other companies’ products, or treatment options on Facebook. These discussions are best held in private with a healthcare professional. Because of these regulations, discussions need to be on-topic and constructive. Comments or private messages on the AbbVie pages that include any of the following are considered not constructive and may be hidden, deleted or not responded to:

• Name our or other companies’ products, or related treatment effect.

• Offer health or medical advice.

• Include profanity, defamatory, libelous, offensive, abusive, discriminatory, harassing, or demeaning content, including images, videos, and links.

• Are disparaging, threatening, condone violence or illegal behavior.

• Contain personal information, like the names of individuals, email addresses, phone numbers, personal photos, or videos.

• Contain proprietary, confidential, sensitive, or non-public information.

• Violate copyright or intellectual property.

• Are commercial in nature, with an intent to sell products and services or recruit fans and followers to other social communities.

• Contain information that is false, inaccurate, or misleading.

• Are excessively repetitive and/or disruptive to the community (SPAM); or violate Facebook’s terms and policies. Please be aware that followers who violate the above rules may be blocked from our Facebook account. In this case, the user would no longer be able to follow our content or comment on our posts. AbbVie is not responsible for and does not assume any liability for any third-party content. Facebook accounts and statements that AbbVie Likes are not an indication of AbbVie’s endorsement of these accounts or the content they produce. Nor is it an indication that we are engaged in a business relationship with the content authors. Any information expressed by AbbVie is subject to the risk factors and information on forward-looking statements contained in its filings with the Securities and Exchange Commission and available at AbbVie.com. Nothing provided on these channels constitutes an offer or invitation to invest or deal in AbbVie securities. Medical side effects

If you believe you have experienced any medical side effects whilst taking an AbbVie product, please discuss your situation with a healthcare professional. You can report any side effects related to HArmonyCa™ at [email protected]

We suggest you avoid sharing specific information concerning your personal health on social media sites and the internet in general. If you decide to direct message us to share any side effects or report a complaint, we will ask for your consent to contact you for more information. This is exclusively for the purposes of AbbVie fulfilling its safety reporting obligations. Using and storing personal identifying information

AbbVie will not disclose or share personal identifying information on its Facebook account unless we have obtained proper consents. We do not store or use your Facebook unique ID, email, or other personal identifying information. However, in the case of reporting a side effect or product issue, we will need to store and use personal identifying information, such as your name, location, health-related information or similar, in accordance with applicable laws. This information is required to be submitted to the AbbVie Pharmacovigilance and Patient Safety department and/or regulatory authorities. We are also required to store your personal identifying information for auditing purposes. In some instances, AbbVie may choose to use third-party service providers to help us manage comments and messages, which means that they too would have access to any personal identifying information you share with us. Such third-party service providers are contractually bound and trained to ensure an adequate protection and security of your personal identifying information. Please note that Facebook also has access to information you share with us. For more details, please refer to Facebook’s Privacy Policy. Thank you for reading and for following AbbVie’s HArmonyCa™ Hong Kong Facebook.